CN108478731A - Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease - Google Patents
Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease Download PDFInfo
- Publication number
- CN108478731A CN108478731A CN201810661787.4A CN201810661787A CN108478731A CN 108478731 A CN108478731 A CN 108478731A CN 201810661787 A CN201810661787 A CN 201810661787A CN 108478731 A CN108478731 A CN 108478731A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 104
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 72
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 35
- 239000002775 capsule Substances 0.000 title claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 46
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 45
- 235000008434 ginseng Nutrition 0.000 claims abstract description 45
- 241000218176 Corydalis Species 0.000 claims abstract description 24
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 22
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 22
- 229940116229 borneol Drugs 0.000 claims abstract description 22
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 22
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 21
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 20
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 20
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 20
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 20
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 20
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 20
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 20
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 20
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 20
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 20
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 20
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 20
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 20
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 20
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 19
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 19
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 19
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 19
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 17
- 241000208671 Campanulaceae Species 0.000 claims abstract description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000001361 Styrax officinalis Nutrition 0.000 claims abstract description 16
- 235000019382 gum benzoic Nutrition 0.000 claims abstract description 16
- 244000138993 panchioli Species 0.000 claims abstract description 16
- 239000002023 wood Substances 0.000 claims abstract description 16
- 244000290970 Tetrapanax papyrifer Species 0.000 claims abstract description 15
- 241000208340 Araliaceae Species 0.000 claims abstract 2
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 244000303379 Styrax officinalis Species 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 11
- 239000006187 pill Substances 0.000 claims description 8
- 235000012907 honey Nutrition 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 46
- 210000004369 blood Anatomy 0.000 abstract description 42
- 230000001737 promoting effect Effects 0.000 abstract description 18
- 230000017531 blood circulation Effects 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 14
- 241000123844 Artemisia anomala Species 0.000 abstract description 13
- 235000014290 Artemisia anomala Nutrition 0.000 abstract description 13
- 206010020772 Hypertension Diseases 0.000 abstract description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 5
- 240000005373 Panax quinquefolius Species 0.000 description 44
- 206010002383 Angina Pectoris Diseases 0.000 description 24
- 241000218628 Ginkgo Species 0.000 description 17
- 241001060310 Styracaceae Species 0.000 description 14
- 238000011282 treatment Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 10
- 239000009636 Huang Qi Substances 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000019991 rice wine Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 241000756943 Codonopsis Species 0.000 description 4
- OEYQBKYISMRWQB-UHFFFAOYSA-N Santal Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 OEYQBKYISMRWQB-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 125000005909 ethyl alcohol group Chemical group 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 244000153234 Hibiscus abelmoschus Species 0.000 description 3
- 240000007890 Leonurus cardiaca Species 0.000 description 3
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 3
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 3
- 241000133134 Saussurea Species 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 241000427159 Achyranthes Species 0.000 description 2
- 235000013073 Acorus gramineus Nutrition 0.000 description 2
- 244000001632 Acorus gramineus Species 0.000 description 2
- 241000271309 Aquilaria crassna Species 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 2
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- 240000007551 Boswellia serrata Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 240000004307 Citrus medica Species 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 240000007311 Commiphora myrrha Species 0.000 description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 241000545744 Hirudinea Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 241000123069 Ocyurus chrysurus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241001499733 Plantago asiatica Species 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 description 2
- 240000001341 Reynoutria japonica Species 0.000 description 2
- 244000272264 Saussurea lappa Species 0.000 description 2
- 235000006784 Saussurea lappa Nutrition 0.000 description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 description 2
- 240000006079 Schisandra chinensis Species 0.000 description 2
- 235000008326 Trichosanthes anguina Nutrition 0.000 description 2
- 244000078912 Trichosanthes cucumerina Species 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000002391 femur head Anatomy 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000258920 Chilopoda Species 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 241001660870 Cyrtomium Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 240000007232 Illicium verum Species 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241001571466 Potentilla discolor Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000008254 Rosa chinensis Species 0.000 description 1
- 235000000664 Rosa chinensis Nutrition 0.000 description 1
- 235000016785 Rosa della China Nutrition 0.000 description 1
- 241001278833 Rosa laevigata Species 0.000 description 1
- 235000000661 Rosa laevigata Nutrition 0.000 description 1
- 241001339782 Scapharca broughtonii Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 240000000260 Typha latifolia Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000009136 dragon's blood Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- CYXKNKQEMFBLER-UHFFFAOYSA-N perhexiline Chemical compound C1CCCNC1CC(C1CCCCC1)C1CCCCC1 CYXKNKQEMFBLER-UHFFFAOYSA-N 0.000 description 1
- 229960000989 perhexiline Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 244000145591 rattan cane Species 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine preparations for treating cardiovascular stasis coronary heart disease, it is made of Radix Salviae Miltiorrhizae, ginkgo leaf, corydalis tuber, Rhizoma Chuanxiong, malt, moutan bark, hawthorn, ginseng, peach kernel, safflower, radix paeoniae rubra, Caulis Spatholobi, Fructus Aurantii, dried orange peel, Artemisia anomala, Radix Glycyrrhizae, Radix Angelicae Sinensis, Radix Rehmanniae, radix bupleuri, dalbergia wood, Radix Paeoniae Alba, Longstamen Onion Bulb, campanulaceae, the stem pith of the rice-paper plant, excrementum pteropi, cassia twig, radix polygonati officinalis, Radix Notoginseng, storax and borneol according to the mass fraction.Has the effects that promoting blood circulation and removing blood stasis, coronary circulation-promoting pain-relieving, cure rate is 90% or more.Meanwhile the hypertension that can induce cardiovascular stasis coronary heart disease, hyperlipidemia can be alleviated or be cured to the Chinese medicine preparation.
Description
Technical field
The present invention relates to the Chinese patent drugs for the treatment of coronary heart disease, and the Chinese medicine for more particularly, to treating cardiovascular stasis coronary heart disease is matched
Side.In addition the invention further relates to using Chinese medicinal capsule, Chinese medicinal pill made of the Chinese medicine preparation.It finds particular application to painstaking effort
Blood stasis blocking type coronary disease and angina pectoris also has certain curative effect for myocardial infarction and heart failure etc..
Background technology
Although coronary heart disease is all coronary artery pathological changes, according to the difference of clinical manifestation, angina pectoris, cardiac muscle can be divided into
Infarct, heart failure and arrhythmia cordis etc., wherein angina pectoris is most commonly seen.Before middle medical drugs treatment coronary heart disease, first to divide
Type is dialectical, and difference is dialectical to be needed to combine using different pharmaceutical.The stagnation of the heart blood is a kind of common type of coronary disease and angina pectoris.It is existing
Patent document disclose it is multiple treatment cardiovascular stasis coronary heart diseases (angina pectoris) Chinese patent drugs.
96115634.1 being related to a kind of traditional Chinese medicine oral liquid for treating coronary heart diseases and angina pectoris.The case shows, Radix Salviae Miltiorrhizae and moutan bark
Be conducive to the obstruction of qi in the chest caused by treating the stagnation of the heart blood.
99102847.3 are related to a kind of rhodiola rosea injection for treating coronary disease and angina pectoris, which extracts from rhodiola root and control
The active ingredient of coronary disease and angina pectoris is treated, which there are obvious curative effects to coronary disease and angina pectoris caused by the stagnation of the heart blood.
02146248.8 (1186069C) is related to a kind of with promoting blood circulation and removing blood stasis, the Chinese medicine preparation of regulating qi-flowing for relieving pain effect, at this
In case, radix bupleuri can soothing liver-qi stagnation, Fructus Aurantii can promoting the circulation of qi go it is stagnant.
200610173375.3 (100546639C) disclose a kind of Chinese herbal medicine pill for treating coronary heart disease, which illustrates
Effect of the borneol in treating heart blood silt.
200710133059.8 treatment palpitation and uneasiness, the Chinese medicine of shortness of breath uncomfortable in chest discloses Radix Rehmanniae, Radix Curcumae and peach kernel has
Conducive to the alleviation stagnation of the heart blood.
200910023341.X or 200910023338.8 disclose treatment coronary heart diseases and angina pectoris medicine pill, text
Offering the middle a small amount of borneol of display can have effect.
200910064559.X is related to a kind of thrombolysis decoction for treating angiocardiopathy, in the case, ginseng, Snakegourd Fruit and Radix Curcumae
Effect in treating type of obstruction of heart-blood angiocardiopathy can be included in term of reference.
200910086871.9 treatment coronary disease and angina pectoris Chinese medicine preparation scheme it is simple, do not repeat.
201110273370.9 (102302550B) discloses the drug for the treatment of coronary heart disease comprising：Ginkgo leaf 20-30
Part, 15-25 parts of Radix Salviae Miltiorrhizae, 10-15 parts of Rhizoma Chuanxiong, 10-15 parts of safflower, 10-15 parts of pseudo-ginseng.This application is using ginkgo leaf as monarch drug in a prescription.
201110267629.9 (102302741B) disclose a kind of Chinese medicinal preparation method for treating the type of obstruction of heart-blood obstruction of qi in the chest,
The component of the Chinese medicine is more, wherein the effect in treating the stagnation of the heart blood such as Artemisia anomala, Caulis Spatholobi, Longstamen Onion Bulb and rhizoma cyperi can be with
The prior art as the application.In addition it is also possible to the Chinese medicine of the treatment type of obstruction of heart-blood palpitaition referring to 201110267624.6
Preparation method.
201210200040.1 are related to treating the safflower traditional Chinese herbal decoction of palpitaition and preparation method comprising safflower 100-140
Part, 200-280 parts of Radix Salviae Miltiorrhizae, 150-210 parts of ganoderma lucidum, 150-210 parts of radix paeoniae rubra, 100-140 parts of Rhizoma Chuanxiong, 150-210 parts of corydalis tuber.The heart
Blood stasis resistance type palpitaition belongs to a kind of performance of angiocardiopathy, can be as reference.In addition, the 201110278139.9 treatment heart
Blood stasis hinders the Chinese medicine preparation for causing palpitaition, also similar with this application.
In addition to above patent document, the drugs such as yufeng ningxin tablets, yufeng ningxin pian, ginkgo-leaf oral liquor and perhexiline injection are certain
Coronary disease and angina pectoris caused by the stagnation of the heart blood can be treated in degree, but similar to existing patented technology, cure rate and curative effect
Have much room for improvement.
Invention content
To solve problem of the prior art, the present invention provides a kind of treat in coronary disease and angina pectoris caused by the stagnation of the heart blood
Medicine composition.The Chinese medicine preparation is according to the anginal feature of cardiovascular stasis coronary heart disease, reasonable compatibility ginkgo leaf, ginseng and excrementum pteropi
Etc. components, reach and without adverse affects treat coronary disease and angina pectoris.
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease, which is characterized in that according to the mass fraction, by following
At being grouped as：200~210 parts of Radix Salviae Miltiorrhizae, 180~210 parts of ginkgo leaf, 135~145 parts of corydalis tuber, 135~145 parts of Rhizoma Chuanxiong, malt
120~129 parts, 120~129 parts of moutan bark, 120~129 parts of hawthorn, 105~110 parts of ginseng, 105~110 parts of peach kernel, safranine
Spend 105~110 parts, 105~110 parts of radix paeoniae rubra, 105~110 parts of Caulis Spatholobi, 90~110 parts of Fructus Aurantii, 86~110 parts of dried orange peel, Liu posts
86~89 parts of slave, 86~89 parts of Radix Glycyrrhizae, 86~89 parts of Radix Angelicae Sinensis, 86~89 parts of Radix Rehmanniae, 86~89 parts of radix bupleuri, 80~110 parts of dalbergia wood,
80~90 parts of Radix Paeoniae Alba, 80~85 parts of Longstamen Onion Bulb, 80~85 parts of campanulaceae, 55~70 parts of the stem pith of the rice-paper plant, 58~60 parts of excrementum pteropi, cassia twig 55~60
Part, 55~60 parts of radix polygonati officinalis, 55~60 parts of Radix Notoginseng, 40~50 parts of storax, 8~10 parts of borneol.
As preferred：210 parts of Radix Salviae Miltiorrhizae, 180 parts of ginkgo leaf, 145 parts of corydalis tuber, 145 parts of Rhizoma Chuanxiong, 129 parts of malt, moutan bark
129 parts, 129 parts of hawthorn, 110 parts of ginseng, 110 parts of peach kernel, 110 parts of safflower, 110 parts of radix paeoniae rubra, 110 parts of Caulis Spatholobi, Fructus Aurantii 90
Part, 86 parts of dried orange peel, 86 parts of Artemisia anomala, 86 parts of Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 86 parts of Radix Rehmanniae, 86 parts of radix bupleuri, 80 parts of dalbergia wood, 80 parts of Radix Paeoniae Alba,
80 parts of Longstamen Onion Bulb, 80 parts of campanulaceae, 70 parts of the stem pith of the rice-paper plant, 60 parts of excrementum pteropi, 60 parts of cassia twig, 60 parts of radix polygonati officinalis, 60 parts of Radix Notoginseng, 50 parts of storax,
8 parts of borneol.
As preferred：200 parts of Radix Salviae Miltiorrhizae, 210 parts of ginkgo leaf, 135 parts of corydalis tuber, 145 parts of Rhizoma Chuanxiong, 120 parts of malt, moutan bark
120 parts, 120 parts of hawthorn, 105 parts of ginseng, 105 parts of peach kernel, 105 parts of safflower, 105 parts of radix paeoniae rubra, Caulis Spatholobi 105, Fructus Aurantii 110
Part, 110 parts of dried orange peel, 89 parts of Artemisia anomala, 89 parts of Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 89 parts of Radix Rehmanniae, 89 parts of radix bupleuri, 110 parts of dalbergia wood, Radix Paeoniae Alba 90
Part, 85 parts of Longstamen Onion Bulb, 85 parts of campanulaceae, 55 parts of the stem pith of the rice-paper plant, 58 parts of excrementum pteropi, 55 parts of cassia twig, 55 parts of radix polygonati officinalis, 55 parts of Radix Notoginseng, storax 40
Part, 10 parts of borneol.
As preferred：205 parts of Radix Salviae Miltiorrhizae, 200 parts of ginkgo leaf, 140 parts of corydalis tuber, 138 parts of Rhizoma Chuanxiong, 125 parts of malt, moutan bark
125 parts, 125 parts of hawthorn, 100 parts of ginseng, 100 parts of peach kernel, 100 parts of safflower, 100 parts of radix paeoniae rubra, 100 parts of Caulis Spatholobi, Fructus Aurantii 100
Part, 100 parts of dried orange peel, 88 parts of Artemisia anomala, 86 parts of Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 88 parts of Radix Rehmanniae, 86 parts of radix bupleuri, 90 parts of dalbergia wood, Radix Paeoniae Alba 85
Part, 82 parts of Longstamen Onion Bulb, 82 parts of campanulaceae, 65 parts of the stem pith of the rice-paper plant, 59 parts of excrementum pteropi, 58 parts of cassia twig, 58 parts of radix polygonati officinalis, 58 parts of Radix Notoginseng, storax 45
Part, 9 parts of borneol.
As preferred：200 parts of Radix Salviae Miltiorrhizae, 200 parts of ginkgo leaf, 140 parts of corydalis tuber, 140 parts of Rhizoma Chuanxiong, 125 parts of malt, moutan bark
125 parts, 125 parts of hawthorn, 100 parts of ginseng, 100 parts of peach kernel, 100 parts of safflower, 100 parts of radix paeoniae rubra, 100 parts of Caulis Spatholobi, Fructus Aurantii 100
Part, 100 parts of dried orange peel, 90 parts of Artemisia anomala, 90 parts of Radix Glycyrrhizae, 90 parts of Radix Angelicae Sinensis, 90 parts of Radix Rehmanniae, 90 parts of radix bupleuri, 100 parts of dalbergia wood, Radix Paeoniae Alba 80
Part, 80 parts of Longstamen Onion Bulb, 80 parts of campanulaceae, 60 parts of the stem pith of the rice-paper plant, 60 parts of excrementum pteropi, 60 parts of cassia twig, 60 parts of radix polygonati officinalis, 60 parts of Radix Notoginseng, storax 40
Part, 10 parts of borneol.
A kind of Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease, which is characterized in that including the Chinese medicine preparation.
It is a kind of for treating the Chinese medicinal pill of cardiovascular stasis coronary heart disease, which is characterized in that including the Chinese medicine preparation and
Honey, mass ratio 1:0.5~1.5.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.
In the Chinese medicine preparation, the solvent is rice wine, and by mass percentage, the proportioning with Chinese medicine preparation is 1:8
~10.
In the Chinese medicine preparation, the solvent is yellow rice wine, and by mass percentage, the proportioning with Chinese medicine preparation is 1:5
~10.
In the Chinese medicine preparation, the solvent is ethyl alcohol, and by mass percentage, the proportioning with Chinese medicine preparation is 1:1
~6.
The Chinese medicine preparation of this treatment cardiovascular stasis coronary heart disease of the present invention has the works such as promoting blood circulation and removing blood stasis, coronary circulation-promoting pain-relieving
With curing mainly the stagnation of the heart blood, cure rate is 90% or more.The Chinese medicine preparation optimizes on the basis of considering each constituent content
The proportioning of ginseng and excrementum pteropi improves effect promoting blood circulation and removing blood stasis.Although the Chinese medicine preparation is formed by several kinds of Chinese medicinal materials compatibility,
It, which is cured mainly, defines, and has no toxic side effect.Meanwhile the height that can induce cardiovascular stasis coronary heart disease can be alleviated or be cured to the Chinese medicine preparation
Blood pressure, hyperlipidemia.
Specific implementation mode
For the apparent present invention that illustrates, some that the prior art provides are summarized first and treat anginal scheme.The back of the body
Scape technology segment has explained, and is no longer described in detail.Patent, patent application and other documents that the application directly quotes, are included in
As reference, other do not make the part expressed, with reference to known technology for this case.
Existing patent document discloses multiple documents for treating coronary heart disease.
201110048251.3 (102119971B) are related to a kind of Chinese medicine for treating coronary heart disease comprising 1-3 parts of peach branch turns over
0.5-1 parts of white 1-3 parts of grass, 0.5-1 parts of Moschus, 2-5 parts of Pemisetum flaccidum Griseb, 1-3 parts of Asiatic plantain and illiciumverum.Coronary heart disease differentiation of symptoms and signs for classification of syndrome is multiple
Miscellaneous, same component is not easy to treat all types of coronary heart disease.
201310342311.1 are related to a kind of drug for treating coronary heart diseases and angina pectoris, the white 20-60g of safflower 20-60g, a round bamboo basket,
Campanulaceae 10-30g, grass-leaved sweetflag 5-15g, cassia twig 10-30g, corydalis tuber 10-20g, Snakegourd Fruit 30-100g, potentilla discolor 10-30g, Moschus
10-30g, root of Aucklandia lappa Decne 10-30g, seed of Oriental arborvitae 20-60g, Caulis Spatholobi 10-30g, Radix Ophiopogonis 10-30g, Asiatic plantain 20-60g, pueraria lobata 10-
30g, thizoma curculiginis 10-20g, excrementum pteropi 10-30g, peach kernel 10-20g, Radix Polygalae 20-60g, lepidium seed 10-30g, big gun first 5-15g, melia toosendan
Sub- 5-15g, rhizoma zingiberis 5-15g, toast grass 10-30g.
201210541518.7 being related to a kind of Chinese medicine preparation for coronary disease and angina pectoris, by the Chinese medicine of following weight proportion
Formula material medicine is prepared：220-260 parts of corydalis tuber, 4-12 parts of Moschus, 4-12 parts of storax, 100-140 parts of Rhizoma Chuanxiong, ginseng
100-140 parts, 6-18 parts of borneol.The borneol thoughts of returning home, liver can control blood stasis.Borneol is toxic, should limit its intake.
201110453345.9 disclose a kind of Chinese medicine preparation for treating coronary disease and angina pectoris, by Radix Codonopsis, Radix Astragali, mulberry
Shen, Rhizoma Chuanxiong, Radix Curcumae, excrementum pteropi, rose, semen litchi and agalloch eaglewood.Radix Codonopsis, Radix Astragali, mulberries, Rhizoma Chuanxiong, Radix Curcumae, excrementum pteropi are equal
To treat the good medicine of qi stagnation and blood stasis type coronary heart disease.
201110174824.7 are related to a kind of drug for treating coronary heart disease, optimize American ginseng total saponins and corydalis tuber second
The proportioning of element.
201110155727.3 are related to treating the Chinese medicine of coronary heart disease comprising 25~50 parts of radix rehmanniae preparata, 10~25 parts of Fructus Corni,
15~30 parts of Herba Cistanches, 5~20 parts of gun additioner, 5~15 parts of ginseng, 15~25 parts of Radix Ophiopogonis, 2.5~10 parts of Schisandra chinensis, cassia twig 5~
15 parts, 5~10 parts of Radix Glycyrrhizae, 10~25 parts of Radix Angelicae Sinensis, 15~50 parts of Radix Astragali, 15~50 parts of Radix Salviae Miltiorrhizae, 1.5~5 parts of santal, fructus amomi 5~
10 parts, 5~15 parts of Rhizoma Chuanxiong, 10~20 parts of hawthorn, 15~25 parts of honeysuckle flower, 15~25 parts of radix scrophulariae, 15~50 parts of Radix Rehmanniae.The case is with same
One component treats all types of coronary heart disease.
Although ancient Chinese medicine has the saying of " ginseng fear excrementum pteropi ", modern TCM is studies have shown that reasonably matching
Or under rational solvent action, people, which participates in excrementum pteropi compatibility, can treat a variety of diseases.For example,《Ginseng, excrementum pteropi compatibility pair
The experimental study of A549 human lung adenocarcinoma cell lines effect》(Traditional Chinese Medicinal College of Liaoning Wang Jin),《Ginseng fears the chemical substance of excrementum pteropi
Basic research》(when treasure's traditional Chinese medical science traditional Chinese medicines howl ring D etc.),《Ginseng is simply analysed with excrementum pteropi " mutual restraint between two drugs "》Liu Yuchun etc.,《Ginseng, five spirits
The modern study of fat compatibility is in progress》(Chinese traditional Chinese medicine magazine Li Lian Jun etc.) has all made this careful research.Certainly, ginseng
Influence of other compositions in prescription, such as Radix Salviae Miltiorrhizae, Radix Astragali etc. are had to take into account that with the proportion compatibility of excrementum pteropi.Existing patent text
Offer the patent formula for also disclosing that some ginseng compatibility's excrementum pteropis.In view of other components in prescription, in this application, ginseng：
Excrementum pteropi is 120~125：74~76.
01131203.3 (1124153B) discloses a kind of medicinal composition for restoring cardiac collaterals, for treating coronary disease and angina pectoris.
It includes the clinically ginseng of Rational Dosage, Radix Codonopsis, radix pseudostellariae, Radix Astragali, Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Chinese yam one of which or several；Water
Leech, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, safflower, radix paeoniae rubra, dalbergia wood, Radix Notoginseng, Radix Curcumae, peach kernel, corydalis tuber, ground bettle, frankincense, dragon's blood, myrrh, chicken blood
Rattan, agalloch eaglewood, curcuma zedoary, trigone, motherwort, excrementum pteropi, the root of bidentate achyranthes, melon wither, the tuber of pinellia, longstamen onion bulb and the almonds, Fructus Aurantii, the dried immature fruit of citron orange, santal, rhizoma cyperi,
It is root of Aucklandia lappa Decne, dried orange peel, campanulaceae, corydalis tuber, the fleece-flower root, Radix Angelicae Sinensis, prepared rehmannia root, Radix Paeoniae Alba, Radix Ophiopogonis, sealwort, borneol, grass-leaved sweetflag, spina date seed, remote
Will, amber, asarum, monkshood, cassia twig, Herba Epimedii, Schisandra chinensis, hawthorn, pueraria lobata, Poria cocos, the root of Dahurain angelica, radix bupleuri, earthworm, Rhizoma Gastrodiae wherein one
Kind or several and scorpio, cicada slough, centipede one of which or several combination preparations.The specific embodiment of the case is more, each group
Point play the role of promoting blood circulation and removing blood stasis, but is whether to be used equally for treatment coronary disease and angina pectoris, needs positive research.
200810127216.9 are related to a kind of medicinal liquor for treating coronary heart disease comprising Radix Salviae Miltiorrhizae, corydalis tuber, hawthorn, ginseng, meat
Osmanthus, Radix Angelicae Sinensis, cordyceps sinensis, safflower, Rhizoma Chuanxiong, tangerine pith, lanatechead saussurea herb with flower, Radix Notoginseng, excrementum pteropi and glutinous rice wine.In the case, people participates in five
Clever fat equivalent.
200810127966.6 disclose a kind of method for the treatment of swine coronary diseases with traditional Chinese medicines, Radix Salviae Miltiorrhizae, corydalis tuber, hawthorn, ginseng,
Chinese cassia tree, Radix Angelicae Sinensis, cordyceps sinensis, safflower, Rhizoma Chuanxiong, tangerine pith, lanatechead saussurea herb with flower, Radix Notoginseng, excrementum pteropi.In the case, ginseng is less than excrementum pteropi.According to
Claim, which can be used for treating swine coronary diseases.
200910234765.0 are related to a kind of Chinese medicine for treating swine coronary diseases, by 40 grams of cassia seed, 50 grams of Radix Salviae Miltiorrhizae, rhizoma anemarrhenae 20
Gram, 30 grams of hawthorn, 10 grams of ginseng, 20 grams of radix paeoniae rubra, 20 grams of Radix Angelicae Sinensis, 20 grams of cordyceps sinensis, 20 grams of safflower, 20 grams of Rhizoma Chuanxiong, peach kernel 20
Gram, 20 grams of lanatechead saussurea herb with flower, 40 grams of motherwort, 50 grams of Radix Notoginseng, 20 grams of excrementum pteropi composition.In the case, the quantity of ginseng is less than excrementum pteropi.
200910019636.X is related to a kind of Chinese medicine preparation and preparation method thereof for treating palace blood comprising ginseng, Radix Astragali,
Cortex Phellodendri, tortoiseshell, scutellaria, the fruit of Cherokee rose, Radix Paeoniae Alba, RADIX POLYGONI MULTIFLORI PREPARATA, moxibustion Radix Glycyrrhizae, Radix Angelicae Sinensis, rhizoma cyperi, gun ginger, radix rehmanniae preparata, Chinese mugwort charcoal, Rhizoma Atractylodis Macrocephalae and
Cyrtomium rhizome charcoal.Ginseng, Radix Astragali, Radix Glycyrrhizae and Radix Angelicae Sinensis etc. are the good medicine for treating qi depression to blood stasis.
201010263713.9 disclose a kind of drug and preparation method thereof for treating coronary heart disease, and people participates in five spirits in the case
The proportioning of fat is 1~20：1~20.Excrementum pteropi contains the ingredient for reducing ginseng effect, and people participates in excrementum pteropi and matches in big ratio range
5, it may be decreased effect or generate side effect.
201210537333.9 a kind of Chinese medicine preparation for treating menorrhalgia is made of each raw material of following parts by weight：Ginseng
20~40 parts, 20~40 parts of Radix Astragali, 10~20 parts of Rhizoma Atractylodis Macrocephalae, 3~9 parts of honey-fried licorice root, 3~9 parts of cimicifugae foetidae, 5~15 parts of donkey-hide gelatin, Radix Rehmanniae 10
~20 parts, 8~15 parts of cattail pollen, 10~30 parts of motherwort, 5~15 parts of excrementum pteropi, 3~9 parts of Radix Notoginseng, 3~9 parts of madder.The Chinese medicine
In component, ginseng is about two to four times of excrementum pteropi.
201010288583.4 a kind of Chinese medicine preparation for treating caput femoris necrosis is disclosed, including：Prepared fleece flower root 10-20
Part, 10-20 parts of prepared rehmannia root, 10-15 parts of Radix Angelicae Sinensis, 10-15 parts of donkey-hide gelatin, 10-20 parts of Radix Paeoniae Alba, 5-10 parts of ginseng, 10-20 parts of Radix Codonopsis,
10-20 parts of radix pseudostellariae, 10-20 parts of Radix Astragali, 10-20 parts of Rhizoma Atractylodis Macrocephalae, 10-20 parts of Chinese yam, 10-15 parts of frankincense, 10-15 parts of myrrh prolong
10-15 parts of Hu rope, 10-15 parts of excrementum pteropi.The case treats caput femoris necrosis in a manner of promoting blood circulation and removing blood stasis, nourishing liver and kidney.
201310468625.6, which disclose a kind of ginseng, activates blood circulation and disperses blood clots the formula of wine, including 20-35 parts of ginseng, corydalis tuber
10-30 parts, 10-30 parts of blood clam, 10-30 parts of madder, 10-30 parts of kelp, 10-30 parts of radish seed, art 10-30 parts wide, Exocarpium Citri Rubrum
10-30 parts, 10-30 parts of excrementum pteropi, 10-30 parts of Herba Lycopi, 10-30 parts of trigone, 10-30 parts of bush, 10-30 parts of leech, root of bidentate achyranthes 10-
30 parts, 10-30 parts of turmeric, 10-30 parts of ivy, 10-30 parts of China rose.The content of ginseng is slightly larger than excrementum pteropi in the case.
The present invention's is this for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, according to the mass fraction, by below at
It is grouped as：200~210 parts of Radix Salviae Miltiorrhizae, 180~210 parts of ginkgo leaf, 135~145 parts of corydalis tuber, 135~145 parts of Rhizoma Chuanxiong, malt
120~129 parts, 120~129 parts of moutan bark, 120~129 parts of hawthorn, 105~110 parts of ginseng, 105~110 parts of peach kernel, safranine
Spend 105~110 parts, 105~110 parts of radix paeoniae rubra, 105~110 parts of Caulis Spatholobi, 90~110 parts of Fructus Aurantii, 86~110 parts of dried orange peel, Liu posts
86~89 parts of slave, 86~89 parts of Radix Glycyrrhizae, 86~89 parts of Radix Angelicae Sinensis, 86~89 parts of Radix Rehmanniae, 86~89 parts of radix bupleuri, 80~110 parts of dalbergia wood,
80~90 parts of Radix Paeoniae Alba, 80~85 parts of Longstamen Onion Bulb, 80~85 parts of campanulaceae, 55~70 parts of the stem pith of the rice-paper plant, 58~60 parts of excrementum pteropi, cassia twig 55~60
Part, 55~60 parts of radix polygonati officinalis, 55~60 parts of Radix Notoginseng, 40~50 parts of storax, 8~10 parts of borneol.
Pharmacology：Radix Salviae Miltiorrhizae can promoting blood circulation, it is inducing meastruation to relieve menalgia.Ginkgo leaf promoting blood circulation and stopping pain, for treating hyperlipidemia, hypertension, hat
Angina pectoris.Corydalis tuber can invigorate blood circulation, promoting the circulation of qi, analgesic.Rhizoma Chuanxiong can blood-activating and qi-promoting, wind-expelling pain-stopping.Malt is with radix bupleuri etc., with controlling liver
The obstruction of the circulation of vital energy is stagnant, Ben Fangzhong, it is preferred to use coloured malt.The moutan bark thoughts of returning home, liver and kidney channel, clearing heat and cooling blood, promoting blood circulation.Hawthorn can pass through
Qi and blood has the work(of promoting blood circulation analgesic.Ginseng can reinforce vital energy, under certain condition can compatibility excrementum pteropi.Peach kernel enters conscience blood
Point, kind to let out stasis, dissolving stasis power is strong, also known as stasis-breaking drug, to treat the common medicine of a variety of stagnation of blood stasis diseases.Safflower can blood-breaking,
Promoting circulation of blood and blood adjust blood, strength to be better than safflower.Radix paeoniae rubra return liver warp, can clearing heat and cooling blood, removing blood stasis and analgesics can match radix bupleuri, moutan bark etc.
It is medicinal.Caulis Spatholobi returns liver and kidney channel, can blood circulation promoting and enriching, menstruction regulating and pain relieving, Chang Peiwu qi and activate blood circulation dredging collateral medicines.Fructus Aurantii nature and flavor, channel tropism,
Function is same with the dried immature fruit of citron orange, but acts on and relatively mitigating.Dried orange peel has pungent row temperature logical, there is the work(of promoting qi circulation and relieving pain, invigorating spleen.Artemisia anomala is good at going
It dissipates, energy blood-breaking promoting menstruation, removing blood stasis and analgesics can match peach kernel, Radix Angelicae Sinensis, Rhizoma Chuanxiong etc..Radix Glycyrrhizae can coordinating the drug actions of a prescription, with the medicine of invigorating the spleen and benefiting qi such as ginseng
Compatibility is used for the card of deficiency-weakness of spleen-QI.Radix Angelicae Sinensis can replenishing and activating blood, menstruction regulating and pain relieving, be used for arthralgia pain due to rheumatism.Radix Rehmanniae clearing heat and cooling blood, yin-nourishing
It promotes the production of body fluid, controls consumption of YIN caused by febrile disease, radix polygonati officinalis can be matched.Radix polygonati officinalis can nourishing yin to moisten dryness, promote the production of body fluid to quench thirst.The moon is held back in Radix Paeoniae Alba blood-nourishing, and soft liver analgesic can match bavin
Recklessly, Radix Angelicae Sinensis.The pungent row hardship of radix bupleuri is let out, and property is apt to item and reaches irritability, and soothing liver-qi stagnation, can control can control stagnation of QI due to depression of the liver.Longstamen Onion Bulb is with Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae
5, control the card of the obstruction of qi in the chest.Campanulaceae facilitaing lung, eliminating the phlegm are distributed in lung channel.Dalbergia wood, which can dissipate, to manage it, can stagnation resolvation regulating qi-flowing for relieving pain, can be with controlling stagnation of QI and blood
Chest side of body trusted subordinate pain, be equal with excrementum pteropi, Rhizoma Chuanxiong and use.Excrementum pteropi can promoting blood circulation and stopping pain, removing blood stasis and hemostasis specially enters Liver Channel blood system, is good at
Promoting blood circulation, removing blood stasis and relieving pain, often with Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae with use.Cassia twig controls heart arteries and veins stasis blocking, chest impediment and cardialgia.Radix Notoginseng can dissipate stasis of blood hemostasis, detumescence it is fixed
Bitterly, with using, then the work(for analgesic therapy of invigorating blood circulation more writes compatibility blood-activating and qi-moving medicinal.The stem pith of the rice-paper plant attaches to the lung and stomach meridians, inducing diuresis for treating strangurtia, associates with Radix Glycyrrhizae etc..
Storax controls the diseases such as the turbid, blood stasis of phlegm, is often equal with borneol and uses.The borneol thoughts of returning home, spleen, lung channel, inducing resuscitation of having one's ideas straightened out, clearing away heat to and alleviating pain.
The above pharmacology is abided by《Chinese Pharmacopoeia》(version in 2010) and《Chinese pharmacology》(New Century higher institutions of Chinese medicine is taught
Material) herbal medicine efficacy and combination principle.But herbal pharmacology is profound, the summary of the above pharmacology and non-present invention whole pharmacology.We
It is formed by a variety of compatibility of drugs, collective effect, Radix Salviae Miltiorrhizae, ginkgo leaf are monarch drug in a prescription, may also differentiate between monarch.
Embodiment one
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease consists of the following compositions according to the mass fraction：It is red
Join 21g, ginkgo leaf 18g, corydalis tuber 14.5g, Rhizoma Chuanxiong 14.5g, malt 12.9g, moutan bark 12.9g, hawthorn 12.9g, ginseng
11g, peach kernel 11g, safflower 11g, radix paeoniae rubra 11g, Caulis Spatholobi 11g, Fructus Aurantii 9g, dried orange peel 8.6g, Artemisia anomala 8.6g, Radix Glycyrrhizae 8.6g,
Radix Angelicae Sinensis 8.6g, Radix Rehmanniae 8.6g, radix bupleuri 8.6g, dalbergia wood 8g, Radix Paeoniae Alba 8g, Longstamen Onion Bulb 8g, campanulaceae 8g, stem pith of the rice-paper plant 7g, excrementum pteropi 6g, cassia twig
6g, radix polygonati officinalis 6g, Radix Notoginseng 6g, storax 5g, borneol 0.8g.
A kind of Chinese medicinal pill for treating cardiovascular stasis coronary heart disease, including the Chinese medicine preparation and honey, mass ratio
It is 1:~1.5.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.In the Chinese medicine preparation, the solvent is rice wine, and by mass percentage, the proportioning with Chinese medicine preparation is 1:8.
Embodiment two
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease consists of the following compositions according to the mass fraction：It is red
Join 20g, ginkgo leaf 20g, corydalis tuber 14g, Rhizoma Chuanxiong 14g, malt 12.5g, moutan bark 12.5g, hawthorn 12.5g, ginseng 10g, peach
Benevolence 10g, safflower 10g, radix paeoniae rubra 10g, Caulis Spatholobi 10g, Fructus Aurantii 10g, dried orange peel 10g, Artemisia anomala 9g, Radix Glycyrrhizae 9g, Radix Angelicae Sinensis 9g, Radix Rehmanniae
9g, radix bupleuri 9g, dalbergia wood 10g, Radix Paeoniae Alba 8g, Longstamen Onion Bulb 8g, campanulaceae 8g, stem pith of the rice-paper plant 6g, excrementum pteropi 6g, cassia twig 6g, radix polygonati officinalis 6g, Radix Notoginseng 6g,
Storax 4g, borneol 1g.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.In the Chinese medicine preparation, the solvent is ethyl alcohol, and by mass percentage, the proportioning with Chinese medicine preparation is 1:3.
Embodiment three
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease consists of the following compositions according to the mass fraction：It is red
Join 20.5g, ginkgo leaf 20g, corydalis tuber 14g, Rhizoma Chuanxiong 13.8g, malt 12.5g, moutan bark 12.5g, hawthorn 12.5g, ginseng
10g, peach kernel 10g, safflower 10g, radix paeoniae rubra 10g, Caulis Spatholobi 10g, Fructus Aurantii 10g, dried orange peel 10g, Artemisia anomala 8.8g, Radix Glycyrrhizae 8.6g,
Radix Angelicae Sinensis 8.6g, Radix Rehmanniae 8.8g, radix bupleuri 8.6g, dalbergia wood 9g, Radix Paeoniae Alba 8.5g, Longstamen Onion Bulb 8.2g, campanulaceae 8.2g, stem pith of the rice-paper plant 6.5g, excrementum pteropi
5.9g, cassia twig 5.8g, radix polygonati officinalis 5.8g, Radix Notoginseng 5.8g, storax 4.5g, borneol 0.9g.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.In the Chinese medicine preparation, the solvent is ethyl alcohol, and by mass percentage, the proportioning with Chinese medicine preparation is 1:6.
Example IV
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease consists of the following compositions according to the mass fraction：It is red
Join 20g, ginkgo leaf 21g, corydalis tuber 13.5g, Rhizoma Chuanxiong 14.5g, malt 12g, moutan bark 12g, hawthorn 12g, ginseng 10.5g, peach
Benevolence 10.5g, safflower 10.5g, radix paeoniae rubra 10.5g, Caulis Spatholobi 10.5, Fructus Aurantii 11g, dried orange peel 11g, Artemisia anomala 8.9g, Radix Glycyrrhizae 8.9g,
Radix Angelicae Sinensis 8.9g, Radix Rehmanniae 8.9g, radix bupleuri 8.9g, dalbergia wood 11g, Radix Paeoniae Alba 9g, Longstamen Onion Bulb 8.5g, campanulaceae 8.5g, stem pith of the rice-paper plant 5.5g, excrementum pteropi
5.8g, cassia twig 5.5g, radix polygonati officinalis 5.5g, Radix Notoginseng 5.5g, storax 4g, borneol 1g.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.In the Chinese medicine preparation, the solvent is ethyl alcohol, and by mass percentage, the proportioning with Chinese medicine preparation is 1:1.
Embodiment five
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease consists of the following compositions according to the mass fraction：It is red
Join 21g, ginkgo leaf 21g, corydalis tuber 15g, Rhizoma Chuanxiong 15g, malt 12g, moutan bark 12g, hawthorn 12g, ginseng 10g, peach kernel 10g,
Safflower 10g, radix paeoniae rubra 10g, Caulis Spatholobi 10g, Fructus Aurantii 10g, dried orange peel 10g, Artemisia anomala 9g, Radix Glycyrrhizae 9g, Radix Angelicae Sinensis 9g, Radix Rehmanniae 9g, bavin
Hu 9g, dalbergia wood 10g, Radix Paeoniae Alba 8g, Longstamen Onion Bulb 8g, campanulaceae 8g, stem pith of the rice-paper plant 6g, excrementum pteropi 6g, cassia twig 6g, radix polygonati officinalis 6g, Radix Notoginseng 6g, storax
4g, borneol 2g.
It is a kind of for treating the Chinese medicinal pill of cardiovascular stasis coronary heart disease, which is characterized in that including the Chinese medicine preparation and
Honey, mass ratio 1:1.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.In the Chinese medicine preparation, the solvent is yellow rice wine, and by mass percentage, the proportioning with Chinese medicine preparation is 1:10.
Embodiment six
A kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease consists of the following compositions according to the mass fraction：It is red
Join 21g, ginkgo leaf 21g, corydalis tuber 13g, Rhizoma Chuanxiong 13g, malt 12g, moutan bark 12g, hawthorn 12g, ginseng 10g, peach kernel 10g,
Safflower 10g, radix paeoniae rubra 10g, Caulis Spatholobi 10g, Fructus Aurantii 10g, dried orange peel 10g, Artemisia anomala 9g, Radix Glycyrrhizae 9g, Radix Angelicae Sinensis 9g, Radix Rehmanniae 9g, bavin
Hu 9g, dalbergia wood 10g, Radix Paeoniae Alba 8g, Longstamen Onion Bulb 8g, campanulaceae 8g, stem pith of the rice-paper plant 6g, excrementum pteropi 6g, cassia twig 6g, radix polygonati officinalis 6g, Radix Notoginseng 6g, storax
6g, borneol 2g.
It is a kind of for treating the Chinese medicinal pill of cardiovascular stasis coronary heart disease, which is characterized in that including the Chinese medicine preparation and
Honey, mass ratio 1:0.5.
It is a kind of for treating the Chinese medicine preparation of cardiovascular stasis coronary heart disease, it is characterised in that including the Chinese medicine preparation and molten
Agent.In the Chinese medicine preparation, the solvent is rice wine, and by mass percentage, the proportioning with Chinese medicine preparation is 1:10.
The dosage of each traditional Chinese medicinal components of above example does not represent one dosage, in practical operation, it is general be divided to it is two daily.
The application does not limit the preparation method of the Chinese medicine preparation, according to Chinese Pharmacopoeia, prepares, takes according to usual method.Certainly,
According to experimental demonstration, ginseng and excrementum pteropi use aqueous solution or drinks of the concentration of alcohol 40% or more, are cooked by slow fire three hours,
It is eaten with other components compatibility, it is better.
Typical case
1, sieve family in Nanchang City, Jiangxi Province collects sieve XX, and long-term pectoralgia enters Night Watch very, and with palpitation and uneasiness.Once in Jiangxi Province
First Affiliated Hospital Of Nanchang University sees a doctor, and inspection result is treatment cardiovascular stasis coronary heart disease angina pectoris.Because of curative effect unobvious, chest
Pain does not improve, and actively abandons curing.After our half a year, pectoralgia does not recur.
2, Jiangxi Duchang County Cai Ling town XXX, with hypertension and with long-term pectoralgia, Zeng Douchang county people's hospital treats,
It is transferred to First Affiliated Hospital Of Nanchang University of Jiangxi Province after invalid.It determines in an attached institute and is twisted with the coronary heart disease heart caused by hypertension
Bitterly, main dialectical type is type of obstruction of heart-blood.Due to many reasons, abandon treating.We are used the year before, by more than ten
The long-term treatment of the moon, pectoralgia gradually slow down, have disappeared, and hypertension is alleviated.
Each traditional Chinese medicinal components of above example can be used for treating cardiovascular stasis coronary heart disease angina pectoris.It is to the painstaking effort stasis of blood
The cure rate of coronary disease and angina pectoris based on resistance is about 90%, if coronary heart disease, caused by hypertension and hyperlipidemia, cure rate is about
It is 92%.In addition, to causing the cure rate of anginal hypertension and hyperlipidemia to be about 76%.
Claims (4)
1. a kind of Chinese medicine for treating cardiovascular stasis coronary heart disease, which is characterized in that according to the mass fraction, by following component group
At：210 parts of Radix Salviae Miltiorrhizae, 180 parts of ginkgo leaf, 145 parts of corydalis tuber, 145 parts of Rhizoma Chuanxiong, 129 parts of malt, 129 parts of moutan bark, hawthorn 129
Part, 110 parts of ginseng, 110 parts of peach kernel, 110 parts of safflower, 110 parts of radix paeoniae rubra, 110 parts of Caulis Spatholobi, 90 parts of Fructus Aurantii, 86 parts of dried orange peel, Liu
Post 86 parts of slave, 86 parts of Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 86 parts of Radix Rehmanniae, 86 parts of radix bupleuri, 80 parts of dalbergia wood, 80 parts of Radix Paeoniae Alba, 80 parts of Longstamen Onion Bulb, campanulaceae
80 parts, 70 parts of the stem pith of the rice-paper plant, 60 parts of excrementum pteropi, 60 parts of cassia twig, 60 parts of radix polygonati officinalis, 60 parts of Radix Notoginseng, 50 parts of storax, 8 parts of borneol, the wheat
Bud is coloured malt.
2. a kind of Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease, which is characterized in that in as described in claim 1
Medicine.
3. a kind of Chinese medicinal pill for treating cardiovascular stasis coronary heart disease, which is characterized in that in as described in claim 1
Medicine and honey, mass ratio 1:0.5~1.5.
4. a kind of Chinese medicine preparation for treating cardiovascular stasis coronary heart disease, it is characterised in that in as described in claim 1
Medicine and solvent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810661787.4A CN108478731A (en) | 2018-06-25 | 2018-06-25 | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810661787.4A CN108478731A (en) | 2018-06-25 | 2018-06-25 | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108478731A true CN108478731A (en) | 2018-09-04 |
Family
ID=63343038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810661787.4A Withdrawn CN108478731A (en) | 2018-06-25 | 2018-06-25 | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108478731A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943901A (en) * | 2016-05-10 | 2016-09-21 | 青岛市第三人民医院 | Traditional Chinese medicinal preparation for treating chest congestion after heart bypass |
| CN110016397A (en) * | 2019-05-14 | 2019-07-16 | 孙建德 | The preparation method of the not bright heart-nourishing liquor of one seed sand |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
| CN115282229A (en) * | 2022-07-05 | 2022-11-04 | 保定中药制药股份有限公司 | Traditional Chinese medicine composition for treating coronary heart disease with syndrome of qi deficiency and blood stasis and preparation method thereof |
-
2018
- 2018-06-25 CN CN201810661787.4A patent/CN108478731A/en not_active Withdrawn
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943901A (en) * | 2016-05-10 | 2016-09-21 | 青岛市第三人民医院 | Traditional Chinese medicinal preparation for treating chest congestion after heart bypass |
| CN110016397A (en) * | 2019-05-14 | 2019-07-16 | 孙建德 | The preparation method of the not bright heart-nourishing liquor of one seed sand |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
| CN115282229A (en) * | 2022-07-05 | 2022-11-04 | 保定中药制药股份有限公司 | Traditional Chinese medicine composition for treating coronary heart disease with syndrome of qi deficiency and blood stasis and preparation method thereof |
| CN115282229B (en) * | 2022-07-05 | 2023-09-29 | 保定中药制药股份有限公司 | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type coronary heart disease and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
| CN107303384B (en) | A Chinese medicinal composition for treating various symptoms, and its derivatives and products | |
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN105920375A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine | |
| CN102845745A (en) | Dendrobium officinale health-care product | |
| CN102188560A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN108478731A (en) | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease | |
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| Bielory et al. | Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma. | |
| CN103230548A (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
| CN103784888A (en) | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis | |
| CN101062368A (en) | Chinese traditional medicine for treating cirrhosis ascites | |
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN112843207A (en) | Formula and preparation method of smearing type thermal moxibustion ointment | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN102626478A (en) | Externally used Chinese herbal medicine compound for treating lumbar muscle strain for years | |
| CN102626443B (en) | Chinese herbal medicine combination for treating gout | |
| CN101912596B (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN103735720B (en) | Chinese medicine composition being used for the treatment of hemiplegia and preparation method thereof | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN105169338A (en) | Medicine composition for treating female climacteric syndromes and preparation method thereof | |
| CN104069421A (en) | Traditional Chinese medicine composition for treating heart diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180904 |